CompoAtlas

KENKODERM Cream

Natural health product licensed in Canada

Licence holder
Olympus Trading Company, LLC
NPN or DIN-HM
80124793
Status
Active licence
Licence date
6 June 2023
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Acide 2-hydroxybenzoïque

Source : Acide salicylique

2 %

Non-medicinal ingredients

Beurre de karité, Phénoxyéthanol, Céramide 1, Carboxypoly(méthylène), Stéarate de glycéryle AÉ, Étholide de limnanthe, Gomme de xanthane, Alcool cétostéarylique, Hydroxyde de sodium, Niacinamide, Alcool cétylique, Urée, Eau distillée, Céramide NP, Lauroyle lactylate de sodium, Diméthicone, Ethylhexylglycérine, Cholestérol, Propylène glycol, Phytosphingosine, Polymère croisé d'hyaluronate de sodium, Edétate de sodium, Méthosulfate de béhéntrimonium, Stéarate de PEG-100, Monostéarate de glycéryle, dl-alpha tocophérol, Glycérine

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

(For the relief of)/(Controls)/(Helps prevent)/(Helps prevent [the] recurrence of)/ (Reduces [the] recurrence of)/(Reduces) dandruff/(and) (the symptoms of) ([skin/scalp] itching/irritation/redness/ flaking [and]/scaling) (associated with dandruff).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80124793

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line